Overview

Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The aim of the FLUID Trial is to conduct a pragmatic, multi-centre, open label randomized cluster cross-over trial (RCT) to determine whether fluid administration with 0.9% saline as compared to Ringer's lactate decreases death or re-admission to hospital with 90 days of the index admission.
Phase:
Phase 4
Details
Lead Sponsor:
Ottawa Hospital Research Institute